symbol,statement_type,period_end,line_item,value
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-2440000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-26860000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,37520000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-20050000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,End Cash Position,5480000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,4250000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,140000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,1090000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,290000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-4170000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-3820000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,10660000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,12490000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,12490000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-1830000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-26860000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,25030000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-16810000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,1540000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,460000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,2100000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-1390000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,49180000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-50570000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-19520000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,530000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-20050000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,17610000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-2380000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1740000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-480000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-340000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-920000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,6890000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,210000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,11230000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Depreciation,11230000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,470000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-1230000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-50000000.0
TATACHEM.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,5680000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,11820000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-13150000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,1660000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-18340000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,End Cash Position,4250000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,5080000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,50000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-880000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-24940000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-2080000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-4460000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-4470000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-4470000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-11490000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,1660000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,1660000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-13150000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-13150000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,0.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-6100000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-640000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,640000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,1850000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,7030000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,45330000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-38300000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-18230000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,110000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-18340000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,30160000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-3870000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,3320000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-4560000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-230000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,8110000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,3060000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,230000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,9800000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,1130000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Depreciation,9800000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,670000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-860000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,470000000.0
TATACHEM.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,8160000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,13930000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-50870000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,38920000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-15780000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,End Cash Position,5080000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,7620000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,370000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-2910000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-20760000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,10000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-3440000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-3190000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-3190000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-11950000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-11950000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-50870000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,38920000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-11860000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,3910000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,480000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,1320000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,1120000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,47860000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-46740000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-15440000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,340000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-15780000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,29710000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-4070000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-6790000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Change In Payable,670000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-2370000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-5090000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,3720000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,90000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,8920000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,1090000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Depreciation,7830000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,820000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-1000000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,300000000.0
TATACHEM.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,27220000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,3680000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-30320000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,29920000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-12770000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,End Cash Position,7620000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,6890000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,190000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,540000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-7550000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,4700000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-2550000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-2550000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-2550000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-400000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-400000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-30320000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,29920000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-8360000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,1720000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,400000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,530000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,1640000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,52200000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-50560000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-12650000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,120000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-12770000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,16450000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-2630000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-6500000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Change In Payable,8370000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-6070000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-8800000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,2530000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,140000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,8060000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Depreciation,8060000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,790000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-700000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,70000000.0
TATACHEM.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,16850000000.0
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,21200000.0
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,-2803600000.0
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Depreciation,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
TATACHEM.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
